EUVIMEDEUVIMED entdecken
Crossref

Characterization of Pro‐Drug Metabolism and Drug Permeability Kinetics in a Microphysiological In Vitro Model of the Human Small Intestinal Barrier Incorporating Mucus‐Generating Cells Coupled with LC‐MS/MS Analysis

Sultan K AlShmmari, Roa S Fardous, Mohammed A ALHamamah, Dana Cialla-May, Jürgen Popp, Qasem Ramadan iD, Mohammed Zourob

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202500692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Sultan K AlShmmari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LP…. Hauptthemen laut MEDLINE: Mucus, Prodrugs, Intestine, Small, Models, Biological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A micro‐physiological model of the human small intestinal barrier incorporating mucus‐generating cells has been developed. The established barrier was utilized to assess the absorption kinetics of three selected therapeutic compounds: Doxycycline, Ganciclovir, and its prodrug Valganciclovir, following the implementation of a thorough LC‐MS/MS validation protocol. The co‐culture of Caco‐2 cells, representing absorptive enterocytes, and HT‐29 MTX cells, modeling goblet cells, enabled the in‐situ generation of a sufficiently thick mucus layer covering the entire cell monolayer. The presence of HT‐29 MTX cells, which exhibit weaker tight junctions than enterocytes, contributed to the observed lower transepithelial electrical resistance (TEER) and higher FITC‐dextran flux. The permeability of all the compounds was higher when tested in the co‐culture system containing mucus‐generating cells, compared to the Caco‐2 monoculture, demonstrating the impact of mucus on intestinal drug transport kinetics. The permeability of ganciclovir following its generation from the prodrug valganciclovir was significantly higher than the permeability of ganciclovir itself, as the active metabolite ganciclovir exhibited an enhanced transport rate compared to when administered without metabolic activation. The developed microfluidic‐based intestinal barrier model has demonstrated the capability to reliably simulate drug absorption and prodrug metabolism, and its impact on drug permeation kinetics across the small intestine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucusProdrugsIntestine, SmallModels, BiologicalIntestinal MucosaHumansCaco-2 CellsTandem Mass SpectrometryPermeabilityChromatography, LiquidHT29 CellsCoculture TechniquesKineticsGanciclovirLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

LC‐MS/MSin vitro modelmucuspharmacokineticspro‐drugsmall intestine

Substanzen

ProdrugsGanciclovir

Autor:innen und Institutionen

  • Leibniz Institute of Photonic Technology, Member of Leibniz Health Technologies, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Albert-Einstein-Straße 9, 07745, Jena, Germany.
  • College of Science & General Studies, Alfaisal University, Riyadh, 11533, Saudi Arabia.
  • Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, G4 0RE, UK.
  • College of Veterinary Medicine, King Faisal University, Hufuf, 31982, Saudi Arabia.
  • Institute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Member of the Leibniz Centre for Photonics in Infection Research (LPI), Helmholtzweg 4, 07743, Jena, Germany.

ORCID-Profile: Qasem Ramadan

Zitieren

APA

AlShmmari, S. K., Fardous, R. S., ALHamamah, M. A., Cialla-May, D., Popp, J., Ramadan, Q., & Zourob, M. (2025). Characterization of Pro‐Drug Metabolism and Drug Permeability Kinetics in a Microphysiological In Vitro Model of the Human Small Intestinal Barrier Incorporating Mucus‐Generating Cells Coupled with LC‐MS/MS Analysis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500692

Vancouver

AlShmmari SK, Fardous RS, ALHamamah MA, Cialla-May D, Popp J, Ramadan Q, et al. Characterization of Pro‐Drug Metabolism and Drug Permeability Kinetics in a Microphysiological In Vitro Model of the Human Small Intestinal Barrier Incorporating Mucus‐Generating Cells Coupled with LC‐MS/MS Analysis. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500692

BibTeX
@article{AlShmmari2025,
  author = {AlShmmari, Sultan K and Fardous, Roa S and ALHamamah, Mohammed A and Cialla-May, Dana and Popp, Jürgen and Ramadan, Qasem and Zourob, Mohammed},
  title = {Characterization of Pro‐Drug Metabolism and Drug Permeability Kinetics in a Microphysiological In Vitro Model of the Human Small Intestinal Barrier Incorporating Mucus‐Generating Cells Coupled with LC‐MS/MS Analysis},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202500692}
}
Kostenlos starten →